Literature DB >> 16512600

The role of immunohistochemistry in the diagnosis of urinary bladder neoplasms.

Jesse K McKenney1, Mahul B Amin.   

Abstract

The spectrum of neoplasms involving the urinary bladder is diverse, and, at times, different entities with distinct prognostic and managerial implications may have significant morphologic overlap. The presence of a neoplasm with an unusual morphologic appearance, such as an undifferentiated spindled, or plasmacytoid pattern may necessitate immunohistochemistry to establish the diagnosis. In this review, we discuss a series of distinct diagnostic scenarios, including high-grade undifferentiated carcinoma versus prostatic adenocarcinoma, enteric-type adenocarcinoma versus secondary colorectal adenocarcinoma, spindle cell proliferations, neoplasms with plasmacytoid morphology, endophytic tumors with a nested growth pattern, and flat urothelial lesions with atypia. We also discuss markers supporting urothelial differentiation in the context of a metastatic carcinoma from an unknown primary. The importance of using a morphologically derived differential diagnosis to guide the selection and interpretation of immunohistochemical studies is emphasized, and the varying utility (specificity) of the individual immunohistochemical markers within each setting is addressed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16512600     DOI: 10.1053/j.semdp.2005.11.005

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  8 in total

1.  [Molecular markers in the diagnostics and therapy of urothelial cancer].

Authors:  C Protzel; O W Hakenberg
Journal:  Urologe A       Date:  2010-11       Impact factor: 0.639

2.  Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery.

Authors:  Frank Heinzelmann; Daniela Thorwarth; Ulf Lamprecht; Theodor W Kaulich; Jörg Fuchs; Guido Seitz; Martin Ebinger; Rupert Handgretinger; Michael Bamberg; Martin Weinmann
Journal:  Strahlenther Onkol       Date:  2011-10-29       Impact factor: 3.621

3.  Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens.

Authors:  Raji Pillai; Rebecca Deeter; C Ted Rigl; J Scott Nystrom; Meredith Halks Miller; Ljubomir Buturovic; W David Henner
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

Review 4.  Adenocarcinoma of the urinary bladder.

Authors:  Vipulkumar Dadhania; Bogdan Czerniak; Charles C Guo
Journal:  Am J Clin Exp Urol       Date:  2015-08-08

5.  Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.

Authors:  Anuradha Gopalan; David S Sharp; Samson W Fine; Satish K Tickoo; Harry W Herr; Victor E Reuter; Semra Olgac
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

6.  Diagnostic Relevance of GATA 3 Expression in Urinary Bladder Carcinoma of Divergent Differentiation and Other Histological Variants.

Authors:  Chanchal Rana; Suresh Babu; Harshita Agarwal; Atin Singhai; Madhu Kumar; Vishwajeet Singh; R J Sinha; S N Shankhwar
Journal:  Indian J Surg Oncol       Date:  2021-08-18

Review 7.  Sarcomatoid variant of urothelial carcinoma (carcinosarcoma, spindle cell carcinoma): a review of the literature.

Authors:  Anthony Kodzo-Grey Venyo; Sami Titi
Journal:  ISRN Urol       Date:  2014-01-22

8.  Comparison of Immunohistochemistry Expression of CK7, HMWK and PSA in High-Grade Prostatic Adenocarcinoma and Bladder Transitional Cell Carcinoma.

Authors:  Reza Gheitasi; Esmaeil Sadeghi; Mohammad Jafari
Journal:  Iran J Pathol       Date:  2020-11-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.